AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2015
Jan 2, 2015
30826_dirs_2015-01-02_34cbc63b-aed6-4e53-8474-cb9308fb1e97.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2014-12-31
Reporting Person: HERLIHY WALTER C (Director, PRESIDENT, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-06-13 | Common Stock | G | 5000 | — | Disposed | 491661 | Direct |
| 2014-09-10 | Common Stock | G | 5000 | — | Disposed | 486661 | Direct |
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23